Jun 2026 (Q2 FY26) — Aug 5, 2026
Medline Q2 FY26 — Strong Top-Line Growth Offset by Margin Headwinds and Strategic Investments
Read the full callMedline (MDLN) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Medline earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 7,685 | +11.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 5.1 | −4.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | Quarterly, as filed | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. |
Price
$35.19 −2.14% · −$0.77
Performance −16.2% YTD
YTD: $42 on 31 Dec 2025 → $35.19. High $49.99 (24 Feb 2026), low $31.64 (18 Sept 2026).
- Previous close
- $35.96
- 52-week range
- $31.64 – $49.99
Overview
- Symbol
- MDLN
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q1 FY26) — May 6, 2026
Medline Q1 FY26 — Strong Sales Growth and Strategic Investments
Read the full callDec 2025 (Q4 FY25) — Feb 25, 2026
Medline Q4 FY25 — Strong Sales Growth and Debt Reduction Post-IPO
Read the full callEvery analysed call
Medline earnings calls (MDLN)
Financials
What the filings say
Net profit, against the quarter before: +3% (quarter to jun 2025 against mar 2025).
| Line item | Mar 2025 | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Sales | 6,644 | 6,886 | 7,352 | 7,685 |
| Operating profit | 571 | 642 | 422 | 395 |
| Operating margin | 8.6% | 9.3% | 5.7% | 5.1% |
| Other income | -233 | -283 | -131 | -160 |
| Interest | 244 | 253 | 165 | 168 |
| Profit before tax | 338 | 359 | 291 | 235 |
| Tax rate | 4.7% | 7.2% | 17.9% | 40.9% |
| Net profit | 319 | 329 | — | — |
| EPS ($ per share) | — | — | 0.16 | 0.07 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Reserves | — | — | -7 |
| Total liabilities | — | 19,454 | 19,198 |
| Fixed assets | — | 4,595 | 4,778 |
| Investments | — | — | 0 |
| Total assets | — | 35,978 | 38,484 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Cash from operations | 1,685 | 1,769 | 1,744 |
| Cash from investing | -312 | -1,493 | -474 |
| Cash from financing | -191 | -1,613 | 399 |
| Net cash flow | 1,186 | -1,335 | 1,692 |
| Capital expenditure | -275 | -354 | -447 |
| Free cash flow | 1,410 | 1,415 | 1,297 |
MDLN revenue by segment
Supply Chain Solutions grew from 53% to 54% of revenue over the last two quarters.
| Segment | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|
| Supply Chain Solutions | 53% | 54% | — |
| Medline Brand | 47% | 46% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Revenue by region
Q2 FY2026 · share of revenue
- US 93%
- Non Us 7%
As MDLN cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
187 filings between Dec 16, 2025 and Oct 8, 2026.
Open market
decisions to buy or sellPurchases
$514.97M
5 purchases by 4 insiders
Sales
$14.86B
50 sales by 11 insiders
4% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 25
- Award — granted as compensation
- 1
- Option exercise — converted options into shares
- 8
- Tax withheld — shares kept back by the company to cover tax
Also filed: 68 other filings, 29 conversions, 1 disposition to issuer.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Hellman & Friedman Capital Partners X (Parallel), L.P. | — | $2.40B | May 28, 2026 |
| BX Mozart ML-2 Holdco L.P. | — | $2.35B | May 28, 2026 |
| BCP 8 Holdings Mozart Manager L.L.C. | — | $2.35B | May 28, 2026 |
| GIC Private Ltd | $365.00M | $1.44B | Oct 8, 2026 |
| Carlyle Mozart Coinvestment Holdings, L.P. | — | $1.63B | Mar 10, 2026 |
| Carlyle Group Inc. | — | $1.63B | Mar 10, 2026 |
| CP Circle ML Holdco GP, LLC | — | $1.07B | Mar 10, 2026 |
| TC Group Cayman Investment Holdings, L.P. | — | $1.07B | Mar 10, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | GIC Private Ltd 10% owner | Sale | 7,816,987 | $274.77M |
| Oct 6, 2026 | GIC Private Ltd 10% owner | Sale | 2,088,987 | $73.22M |
| Oct 6, 2026 | GIC Private Ltd 10% owner | Sale | 7,183,013 | $251.76M |
| Oct 5, 2026 | GIC Private Ltd 10% owner | Sale | 1,688,690 | $60.42M |
| Oct 2, 2026 | GIC Private Ltd 10% owner | Sale | 2,570,999 | $90.88M |
| Oct 2, 2026 | GIC Private Ltd 10% owner | Sale | 7,146,941 | $245.35M |
| Aug 14, 2026 | GIC Private Ltd 10% owner | Sale | 100,000 | $3.58M |
| Aug 13, 2026 | GIC Private Ltd 10% owner | Sale | 1,500,000 | $53.70M |
| Aug 7, 2026 | GIC Private Ltd 10% owner | Sale | 590,284 | $21.00M |
| Aug 6, 2026 | Mozart Holdco, Inc. 10% owner | Conversion | 500,000 | $0 |
| Aug 6, 2026 | GIC Private Ltd 10% owner | Sale | 271,994 | $9.61M |
| Aug 6, 2026 | Mozart Holdco, Inc. 10% owner | Other | 500,000 | $0 |
| Aug 5, 2026 | GIC Private Ltd 10% owner | Sale | 265,711 | $9.69M |
| Aug 5, 2026 | GIC Private Ltd 10% owner | Sale | 1,710,907 | $60.67M |
| Jun 16, 2026 | Golwas Douglas P Chief Commercial Officer | Disposition to issuer 10b5-1 plan | 100,000 | — |
| Jun 16, 2026 | Golwas Douglas P Chief Commercial Officer | Sale 10b5-1 plan | 61,966 | $2.27M |
| Jun 16, 2026 | Golwas Douglas P Chief Commercial Officer | Sale 10b5-1 plan | 38,034 | $1.41M |
| Jun 16, 2026 | Golwas Douglas P Chief Commercial Officer | Option exercise 10b5-1 plan | 100,000 | — |
| Jun 15, 2026 | Drazin Michael B Chief Financial Officer | Tax withheld | 1,889 | $69.2K |
| Jun 15, 2026 | Golwas Douglas P Chief Commercial Officer | Tax withheld 10b5-1 plan | 1,889 | $69.2K |
| Jun 15, 2026 | Shryock Christopher P Chief Human Resources Officer | Tax withheld | 872 | $31.9K |
| Jun 15, 2026 | Abrams William J See Remarks | Tax withheld | 1,308 | $47.9K |
| Jun 15, 2026 | Boyle James M Chief Executive Officer | Tax withheld | 2,370 | $86.8K |
| Jun 15, 2026 | Miller Stephen L Chief Operating Officer | Tax withheld | 1,889 | $69.2K |
| Jun 15, 2026 | Liberman Alexander M. Chief Legal Officer | Tax withheld | 872 | $31.9K |
| Jun 15, 2026 | Laabs Amanda H. Chief Product Officer | Tax withheld | 1,889 | $69.2K |
| Jun 11, 2026 | GALANTI RICHARD A Director | Award | 5,387 | $0 |
| Jun 11, 2026 | Sweet Thomas W Director | Award | 5,387 | $0 |
| Jun 11, 2026 | Bluedorn Todd M Director | Award | 5,387 | $0 |
| Jun 5, 2026 | CORCORAN JESSI L Principal Accounting Officer | Purchase | 5,000 | $170.8K |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C. 10% owner | Sale | 1,489,924 | $54.44M |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C. 10% owner | Sale | 2,256,800 | $82.46M |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C. 10% owner | Sale | 9,858,774 | $360.21M |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C. 10% owner | Sale | 19,712,326 | $720.24M |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. 10% owner | Other | 209,530 | — |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. 10% owner | Other | 1,536,907 | — |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. 10% owner | Sale | 17,947,337 | $655.75M |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. 10% owner | Sale | 1,262,726 | $46.14M |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. 10% owner | Sale | 11,904,646 | $434.97M |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. 10% owner | Sale | 753,528 | $27.53M |
| May 28, 2026 | HEALY PATRICK J Director | Other | 22,344 | — |
| May 28, 2026 | HEALY PATRICK J Director | Other | 179,762 | — |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P. 10% owner | Other | 438,214 | — |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P. 10% owner | Sale | 1,489,924 | $54.44M |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P. 10% owner | Sale | 2,256,800 | $82.46M |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. 10% owner | Other | 141,364 | — |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P. 10% owner | Sale | 9,858,774 | $360.21M |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P. 10% owner | Sale | 19,712,326 | $720.24M |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C. 10% owner | Other | 438,214 | — |
| May 21, 2026 | BCP 8 Holdings Mozart Manager L.L.C. 10% owner | Other | 1,489,924 | — |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Medline Inc.
Free account. Everything above stays public.
Write why you follow Medline Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading